Who owns APOGEE THERAPEUTICS INC?
- Ticker: APGE
- CUSIP Number: 03770n101
Tip: Access positions for across all investors
Analyze quarterly positions in Apogee Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apogee Therapeutics stock
Who bought or sold APOGEE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| VR Adviser | 8.5M | $237M | 0% | Dec 2023 |
|
| Fairmount Funds Management | 2.9M | $82M | 0% | Dec 2023 |
|
| RA Capital Management | 2.0M | $55M | 0% | Dec 2023 |
|
| Perceptive Advisors | 1.8M | $51M | 0% | Dec 2023 |
|
| Wellington Management Company | 1.6M | $44M | 0% | Dec 2023 |
|
| OrbiMed Advisors | 1.3M | $36M | -11% | Dec 2023 |
|
| Vanguard Group | 1.2M | $33M | 4% | Dec 2023 |
|
| Franklin Resources | 1.1M | $30M | 9% | Dec 2023 |
|
| T. Rowe Price Associates | 771k | $22M | 25% | Dec 2023 |
|
| Point72 Asset Management | 708k | $20M | 90% | Dec 2023 |
|
| Braidwell | 681k | $19M | 39% | Dec 2023 |
|
| Bank of America Corporation | 489k | $14M | 2278% | Dec 2023 |
|
| Henderson Group | 480k | $13M | -20% | Dec 2023 |
|
| Dr. Jeffrey R. Jay, M.D. | 400k | $11M | 0% | Dec 2023 |
|
| Frazier Life Sciences Management | 400k | $11M | 0% | Dec 2023 |
|
| Blackstone Group | 352k | $9.8M | 18% | Dec 2023 |
|
| Commodore Capital | 250k | $7.0M | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 156k | $4.4M | 3% | Dec 2023 |
|
| Bank of New York Mellon | 137k | $9.1M | 109% | Mar 2024 |
|
| Jennison Associates | 104k | $2.9M | 100% | Dec 2023 |
|
| Holocene Advisors | 101k | $2.8M | 0% | Dec 2023 |
|
| TD Asset Management | 101k | $2.8M | 217% | Dec 2023 |
|
| Arrowpoint Asset Management | 79k | $2.2M | 0% | Dec 2023 |
|
| Soleus Capital Management | 35k | $978k | 0% | Dec 2023 |
|
| Barclays | 34k | $952k | 100% | Dec 2023 |
|
| Swiss National Bank | 33k | $922k | 100% | Dec 2023 |
|
| Sphera Funds Management | 30k | $838k | 0% | Dec 2023 |
|
| Millennium Management | 29k | $804k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 28k | $775k | 177% | Dec 2023 |
|
| Rhumbline Advisers | 27k | $761k | 3% | Dec 2023 |
|
| Two Sigma Investments | 25k | $700k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 23k | $644k | 74% | Dec 2023 |
|
| Teachers Retirement System Of The State Of Kentucky | 22k | $622k | 0% | Dec 2023 |
|
| Hudson Bay Capital Management | 20k | $559k | 100% | Dec 2023 |
|
| Jump Financial | 18k | $513k | 100% | Dec 2023 |
|
| Victory Capital Management | 16k | $442k | 0% | Dec 2023 |
|
| Credit Suisse | 15k | $412k | 100% | Dec 2023 |
|
| State of Wisconsin Investment Board | 14k | $385k | 100% | Dec 2023 |
|
| Jane Street | 13k | $375k | -34% | Dec 2023 |
|
| Alliancebernstein | 11k | $297k | 100% | Dec 2023 |
|
| MetLife Investment Advisors | 11k | $297k | 0% | Dec 2023 |
|
| Artia Global Partners | 10k | $290k | 100% | Dec 2023 |
|
| Legal & General Group | 10k | $289k | 225% | Dec 2023 |
|
| American International | 10k | $285k | 5% | Dec 2023 |
|
| Norges Bank Investment Management | 9.2k | $258k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 9.0k | $251k | 113% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 7.7k | $214k | 67% | Dec 2023 |
|
| SG Americas Securities | 6.6k | $185k | 34% | Dec 2023 |
|
| Royal Bank of Canada | 6.4k | $180k | 119% | Dec 2023 |
|
| Wells Fargo & Company | 5.9k | $164k | 33% | Dec 2023 |
|
| China Universal Asset Management | 5.6k | $155k | 100% | Dec 2023 |
|
| Raymond James Financial Services Advisors | 4.9k | $324k | 100% | Mar 2024 |
|
| Legato Capital Management | 4.8k | $318k | 100% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 4.1k | $114k | 0% | Dec 2023 |
|
| Virtus ETF Advisers | 4.0k | $111k | 100% | Dec 2023 |
|
| Citigroup | 3.8k | $105k | 100% | Dec 2023 |
|
| Summit Investment Advisors | 2.0k | $55k | 0% | Dec 2023 |
|
| Amalgamated Bank | 1.4k | $92k | -38% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.2k | $33k | 0% | Dec 2023 |
|
| Daiwa Securities Group | 196.00 | $5.0k | 100% | Dec 2023 |
|
| nVerses Capital | 100.00 | $6.6k | 100% | Mar 2024 |
|
| Washington Trust Advisors | 96.00 | $2.7k | 0% | Dec 2023 |
|
| Red Tortoise | 94.00 | $6.2k | 0% | Mar 2024 |
|
| Bellevue Asset Management | 36.00 | $2.4k | 100% | Mar 2024 |
|
| GAMMA Investing | 13.00 | $863.999500 | 100% | Mar 2024 |
|
| Glassman Wealth Services | 12.00 | $335.000400 | 100% | Dec 2023 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Apogee Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vivo Capital | Dec 2023 | 400k | $11M |
| Citadel Advisors | Sep 2023 | 243k | $5.2M |
| Tudor Investment Corporation | Sep 2023 | 13k | $267k |
| Bayesian Capital Management | Sep 2023 | 11k | $237k |
| Davidson Kempner Capital Management | Sep 2023 | 10k | $213k |
| Meeder Asset Management | Sep 2023 | 6.6k | $141k |
| UBS Group | Sep 2023 | 3.6k | $76k |
| Pnc Financial Services | Sep 2023 | 48.00 | $1.0k |